Effective date, January 1, 2027.
Summary
The bill requires school districts to adopt policies that let students use prescribed bronchodilators or epinephrine autoinjectors themselves at school, during school‑sponsored activities, in before‑ or after‑school care, and while in transit. It sets rules for written treatment plans, parental documentation, and backup medication storage, and gives school staff immunity from civil or criminal liability when they help, unless they act with gross negligence. The goal is to ensure rapid treatment for life‑threatening asthma attacks or allergic reactions.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1504 changes status, plus AI-powered summaries and stage predictions.
Sign up free